AMNEAL PHARMACEUTICALS, INC. Payments to Acquire Additional Interest in Subsidiaries
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Payments to Acquire Additional Interest in Subsidiaries of $2.50 million for the 1-month period ending 2020-09-30, per its 10-K filed 2023-03-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries · last filed 2023-03-03
| Period end | Payments to Acquire Additional Interest in Subsidiaries 1 month | Payments to Acquire Additional Interest in Subsidiaries 1 month as first filed | Payments to Acquire Additional Interest in Subsidiaries 12 month |
|---|---|---|---|
| 2020-09-30 | $2.50M 10-K · filed 2023-03-03 | $2.00M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $3.00M 10-K · filed 2021-03-01 | $3.50M 10-K · filed 2019-03-01 | $3.00M 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |